Dual ACE/NEP inhibitors - more than playing the ACE card.
Baker Heart Research Institute, Danielle Alberti JDRF Centre for Diabetes Complications, Wynn Domain, Melbourne, Victoria, Australia. Karin.jandeleit-dahm@baker.edu.au
K A M
KA
Jandeleit-Dahm
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D001794:Blood Pressure / Q000187:drug effects; D006801:Humans; D006973:Hypertension / Q000188:drug therapy / Q000201:enzymology / Q000503:physiopathology; D015260:Neprilysin / Q000037:antagonists & inhibitors*; D013844:Thiazoles / Q000627:therapeutic use*; D016896:Treatment Outcome
D000806:Angiotensin-Converting Enzyme Inhibitors; C475484:GW660511X; D013844:Thiazoles; D015260:Neprilysin